We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.37%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.4B
AUM Growth
-$234M
(-0.62%)
Cap. Flow
-$832M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.05%
Holding
2,051
New
47
Increased
483
Reduced
1,317
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$240M |
| 2 |
Sysco
SYY
|
+$180M |
| 3 |
Synopsys
SNPS
|
+$83.9M |
| 4 |
C.H. Robinson
CHRW
|
+$42.1M |
| 5 |
United Bankshares
UBSI
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$216M |
| 2 |
Apple
AAPL
|
+$189M |
| 3 |
Microsoft
MSFT
|
+$115M |
| 4 |
Meta Platforms (Facebook)
META
|
+$68.7M |
| 5 |
Broadcom
AVGO
|
+$65.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.13% |
| 2 | Consumer Staples | 11.3% |
| 3 | Industrials | 10.65% |
| 4 | Financials | 9.24% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Allogene Therapeutics
ALLO
$601M
| $59.5K | ﹤0.01% |
25,545
-3,224
| -11% | -$9.51K |
|
1727
Gray Television
GTN
$407M
| $58.9K | ﹤0.01% |
11,323
-3,865
| -25% | -$22.6K |
|
1728
Lexicon Pharmaceuticals
LXRX
$1.02B
| $58.3K | ﹤0.01% |
34,725
+979
| +3% | +$1.76K |
|
1729
Acco Brands
ACCO
$369M
| $58.2K | ﹤0.01% |
12,377
-4,226
| -25% | -$21.1K |
|
|
LAZR
1730
DELISTED
Luminar Technologies
LAZR
| $58.1K | ﹤0.01% |
2,600
-888
| -25% | -$21K |
|
1731
TETRA Technologies
TTI
$1.23B
| $58.1K | ﹤0.01% |
16,791
-5,731
| -25% | -$22.9K |
|
1732
Vivid Seats
SEAT
$77M
| $57.5K | ﹤0.01% |
500
-171
| -25% | -$18.6K |
|
1733
Nuvation Bio
NUVB
$2.24B
| $57K | ﹤0.01% |
19,513
-6,660
| -25% | -$20.3K |
|
1734
Community Health Systems
CYH
$385M
| $56.6K | ﹤0.01% |
16,841
-5,749
| -25% | -$19.3K |
|
1735
Lyell Immunopharma
LYEL
$309M
| $56.5K | ﹤0.01% |
1,949
-500
| -20% | -$23.8K |
|
|
NXDR
1736
Nextdoor Holdings
NXDR
$835M
| $55.7K | ﹤0.01% |
20,033
-6,840
| -25% | -$15.8K |
|
1737
Adtran
ADTN
$798M
| $55K | ﹤0.01% |
10,455
-5,118
| -33% | -$26.1K |
|
|
SHCR
1738
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $54.9K | ﹤0.01% |
40,690
-13,891
| -25% | -$11.4K |
|
|
TELL
1739
DELISTED
Tellurian Inc.
TELL
| $54.3K | ﹤0.01% |
78,332
-26,739
| -25% | -$14.8K |
|
1740
Nokia
NOK
$50.8B
| $54.2K | ﹤0.01% |
14,348
+1,230
| +9% | +$4.55K |
|
|
SAVE
1741
DELISTED
Spirit Airlines, Inc.
SAVE
| $53.8K | ﹤0.01% |
14,705
-5,019
| -25% | -$19.4K |
|
1742
AbCellera Biologics
ABCL
$1.62B
| $53.7K | ﹤0.01% |
18,152
-2,366
| -12% | -$8.95K |
|
1743
Xometry
XMTR
$4.77B
| $52.6K | ﹤0.01% |
+4,549
| New | +$71.5K |
|
1744
Precigen
PGEN
$1.93B
| $52.5K | ﹤0.01% |
33,215
-7,881
| -19% | -$11.4K |
|
|
MPT
1745
Medical Properties Trust
MPT
$2.89B
| $51.7K | ﹤0.01% |
11,985
-1,118
| -9% | -$5.36K |
|
1746
Atea Pharmaceuticals
AVIR
$379M
| $51.2K | ﹤0.01% |
15,466
-4,205
| -21% | -$15.7K |
|
1747
MacroGenics
MGNX
$235M
| $51.1K | ﹤0.01% |
12,018
-3,264
| -21% | -$31.8K |
|
|
CNSL
1748
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $51K | ﹤0.01% |
11,587
-3,554
| -23% | -$15.4K |
|
1749
SelectQuote
SLQT
$114M
| $50.4K | ﹤0.01% |
18,276
-6,240
| -25% | -$15K |
|
|
EB
1750
DELISTED
Eventbrite
EB
| $50.2K | ﹤0.01% |
10,362
-5,659
| -35% | -$29.5K |
|
Similar funds
ProShare Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, ProShare Advisors held 2,051 positions worth $37.4B, down 0.62% from $37.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
ProShare Advisors's Q2 2024 filing shows 47 new, 483 increased, 1,317 reduced and 203 closed positions. Its largest new stake was KKR & Co: 135,149 shares worth $14.2M. The largest sale was 3M, an estimated $216M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q2 2024 buy was KKR & Co: 135,149 shares worth $14.2M.
- ProShare Advisors added most to Qualcomm in Q2 2024, an estimated $240M increase.
- ProShare Advisors's biggest Q2 2024 reduction was 3M, cutting an estimated $216M.
- ProShare Advisors fully exited Leggett & Platt in Q2 2024, selling an estimated $24.6M.
- ProShare Advisors's ten largest holdings make up 26% of its $37.4B portfolio in Q2 2024.
- ProShare Advisors opened 47 new positions and closed 203 in Q2 2024.
- ProShare Advisors's portfolio value fell 0.62% quarter-over-quarter to $37.4B.
Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.